Abstract
Mycobacterium tuberculosis, the causative agent of tuberculosis, is expected to cause 30 million deaths in the coming 10 years — more than any other single infectious agent. The current vaccine against tuberculosis, bacille Calmette-Guérin (BCG), has a highly variable record of protection, and a widely accepted need exists for improved vaccines to control this disease. Infection with tuberculosis triggers a broad spectrum of immune responses which can contribute to elimination of the pathogen and to disease-associated pathology. In an ideal world a complete understanding of these responses would have provided an optimal rational design for improved prophylactic, or therapeutic, vaccines against tuberculosis and other mycobacterial diseases such as leprosy. However, the complexity of this immune response has thus far confronted us with a formidable obstacle, and novel vaccine strategies currently are still based on more pragmatic arguments. In the first part of this chapter we summarise the current knowledge of the host response to mycobacterial pathogens in order to highlight its complex role in protection and disease. The second part describes current approaches taken to produce novel, improved vaccines against mycobacterial pathogens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams E, Basten A, Rodda S, Britton WJ (1997) Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define Mycobacterium specific epitopes rather than shared epitopes. Infect Immun 65:1061–1070
Andersen P (1994) Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62:2536–2544
Andersen P Heron I (1993) Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun 61:844–851
Andersen P Askgaard D, Ljungqvist L, Bennedsen J, Heron I (1991) Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 59:1905–1910
Armstrong JA, Hart PD (1975) Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 142:1–16
Balasubramanian V, Pavelka M Jr, Bardarov SS, Martin J, Weisbord TR, McAdam RA, Bloom BR, Jacobs W Jr (1996) Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol 178:273–279
Barker LP, George KM, Falkow S, Small PLC (1997) Differential Trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect Immun 65:1497–1504
Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB (1994) Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372:691–694
Behr C, Poupot R, Peyrat MA, Poquet Y, Constant P, Dubios P, Bonneville M, Fournie JJ (1996) Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun 64:2892–2896
Bloom BR, Fine PEM (1994) The BCG experience:implications for future vaccines against tuberculosis. In:Bloom BR (ed) The BCG experience:implications for future vacines against tuberculosis. ASM, Washington DC, pp 531–558
Chan J, Kaufmann SHE (1994) Immune mechanisms of protection. In:Bloom, BR (ed) Immune mechanisms of protection. ASM, Washington DC, pp 389–416
Chan J, Xing Y, Magliozzo RS, Bloom BR (1992) Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111–1122
Chatterjee D, Roberts AD, Lowell K, Brennan PJ, Orme IM (1992) Structural basis on capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect immune 60:1249–1253
Clemens DL, Horwitz MA (1995) Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 181:257–270
Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698–702
Convit J, Sampson C, Zuniga M, Smith PG, Plata J, Silva J, Molina J, Pinardi ME, Bloom BR, Salgado A (1992) Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy:preliminary results. Lancet 339:446–450
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243–2247
Copper AM, D’Souza C, Frank AA, Orme IM (1997) The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin-or grandzyme-mediated cytolytic mechanisms. Infect Immun 65:1317–1320
Dannenberg AM Rook GAW (1994) Pathogenesis of pulmonary tuberculosis:an interplay of tissue- damaging and macrophage-activating immune responses - dual mechanisms that control bacillary multiplication. In:Bloom BR (ed) Pathogenesis of pulmonary tuberculosis:an interplay of tissue-damaging and macrophage activating immune responses-dual mechanisms that control bacillary multiplication. ASM, Washington, pp 459–484
de-Cock KM (1994) Impact of interaction with HIV. In:Porter JDH, McAdam KPWJ (eds) Impact of interaction with HIV. Wiley, Chichester, pp 35–49
Denis M (1991) Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell immunol 132:150–157
Denis O, Lozes E, Huygen K (1997) Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. Infect Immun 65:676–684
Ding AH, Nathan CF, Stuehr DJ (1998) release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141:2407–2412
D’Souza CD, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM (1997) An anti-inflammatory role for γδT lumphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 158:1217–1221
Flesch IEA, Kaufmann SHE (1991) Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages:role of reactive nitrogen intermediates. Infect Immun 59:3213–3218
Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 89:12013–12017
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249–2254
Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561–572
Fulton SA, Johnsen JM, Wolf SA, Sieburth DS, Boom WH (1996) Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis:role of phagocytosis. Infect Immun 64:2523–2531
Gelber RH, Murray L, Siu P, Tsang M (1992) Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long- term protection against M. leprae infection. Infect Immun 60:1840–1844
Gelber RH, Mehra V, Bloom B, Murray LP, Siu P, Tsang m, Brennan PJ (1994) Vaccination with pure Mycobacterium leprae proteins inhibits M. Leprae proteins inhibits M. leprace multiplication in mouse footpads. Infect Immun 62:4250 - 4255
Guleria I, McAdam RA, Kalpana G, Jacobs WR, Bloom BR (1996) Auxotrophic vaccines for tuberculosis. Nature Med 2:334 - 337
Hasan Z, Schlax C, Kuhn L, Lefkovits I, Young D, Thole J, Pieters J (1997) Isolation and characterization of the mycobacterial phagosome:segregation from the endosomal/lysosomal pathway. Mol Microbiol
Hermann JL, O’Gaora p, Gallagher A, Thole JER, Young DB (1996) Bacterial glycoproteins:a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO 15:3547–3554
Hsieh CS, MAcatonia SE, Tripp CS, Wolf SF, O’Gara A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547–549
Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, Dewitt CM, Orme IM, Baldwin S, D’Souza C, Drowart A, Lozes E, Vanden bussche P, Van Vooren J-P, Liu MA, Ulmer JB (1996) Imunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med 2:893–898
Inaba K, Inaba M, Naito M, Steinman RM (1993) Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 178:479–488
Karonga Prevention Trial Group (1996) Randomised controlled trial of single BCG, prevention of repeated BCG, or combined BCG and killed Mycobacterium leprosy vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348:172–24
Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SH (1995) Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol 25:2877–2881
Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF (1996) Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 64:1351–1356
Lindblad ER, Elhay MJ, Silva R, Appelberg R, Andersen P (1997) Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect immune 65:623–629
Mahairas GC, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178:1274–1282
Marshall BG, Chambers MA, Wangoo A, Shaw RJ, Young DB (1997) Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant. Infect Immun
Mazzaccaro RJ, Gedde M, Jensen ER, van Santen HM, Ploegh HL, Rock KL, Bloom BR (1996) Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 93:11786–11791
McAdam RA, Weisbrod TR, Martin J, Scuderi JD, Brown AM, Cirillo JD, Bloom BR, Jacobs WR (1995) In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenisis. Infect Immun 63:1004–1012
McDonough KA, Kress Y, Bloom BR (1993) Pathogenesis of tuberculosis:interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 61:2763 - 2773
Murray PJ, Aldovini A, Young RA (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacilli Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci USA 93:934–939
Newport MJ, Huxley CMP, Huston S, Hawrylowycz C, Oostra BA, Williamson R. Levin M (1996) Mutation in the interferon-γreceptor and mycobacterial susceptibility in man. N Engl J Med 335:1941–1949
Nicholson S, da Bonecini Almeida MG, Lapa e Silva JR, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, Linhares C, Rom W, Ho JL (1996) Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 183:2293–2302
Nussler Ak, Billiar TR (1993) Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 54:171–178
O’Brien RL, Happ MP, Dallas A, Palmer E, Kubo R, Born WK (1989) Stimulation of a major subset of lymphocytes expressing T cell receptor gammadelta by an antigen derived from Mycobacterium tuberculosis. Cell 57:667–674
O’Donnell MA, Aldovini A. Duda RB, Yang H, Szilvasi A, Young RA, DeWolf WC (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 62:2508–2514
Orme IM, Anderson P, Boom WH (1993) T cell response to Mycobacterium tuberculosis. J Infect Dis 167:1481–1497
Ottenhoff THM, Mutis T (1990) Specific killing of cytotoxic T cells and antigen presenting cells by cytotoxic CD4+ T cell clones. A novel potentially immunoregulatory T-T cell interaction in man. J Exp Med 171:2011–2024
Pal PG, Horwitz MA (1992) Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell–mediated immune responses and substantial protective immunity n a guinea pig model of pulmonary tuberculosis. Infect Immun 60:4781–4792
Pancholi P, Mirza A, Bhardwaj N. Steinman RM (1993) Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science 260:984–986
Pelicic V, Reyrat JM, Gicquel B (1996) Expression of the subtilis sacB gene confers sucrose sensitivity on mycobacteria. J Bacteriol 178:1197–1199
Philipp WJ, Nair S, Guglielmi G, Lagandrie M, Gicquel B, Cole ST (1996) physical mapping of Mycobacterium bovis BCG Pasteur reveals differences from the genome maps of Mycobacterium tuberculosis H37Rv and M. bovis. Microbiology 142:3135–3145
Ponnighaus JM, Fine PE, Sterne JA, Wilson RJ, Msosa E, Gruer PJ, Jenkins PA, Lucas SB, Liomba NG, Bliss L (1992) Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 339:636–639
Reyrat JM, Berthet FX, Gicquel B (1995) The urease locus of M. tuberculosis and its utilisation for the demonstration of allelic exchange in M. bovis BCG. Proc Natl Acad Sci USA 92:8768–8772
Rook GAW, Hernandez-Pando R (1996) the pathogenesis of tuberculosis. Annu Rev Microbiol 50:259–284
Sampaio EP, Kaplan G, Miranda A, Nery JA, Miguel CP, Viana SM, Sarno EN (1993) The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 168:408–414
Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ (1995) CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227–230
Silva CL, Lowrie DB (1994) A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology 82:224–248
Silva CL, Silva RC, Pietro RCLR, Lowrie DB (1994) Protection against tuberculosis by passive transfer with T-cell clones recognising mycobacterial heat-shock protein 65. Immunology 83:341–346
Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB (1995) Purification and characterisation of a low- molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63:1710–1717
Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF et al (1991) New use of BCG for recombinant vaccines. Nature 351:456–460
Sturgill-Koszycki S, Schlesinger PH, Charkraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL,Heuser J, Rusell DG (1994) Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678–681
Sugita M, Jackman RM, van-Donselaar E, Behar SM, Rogers RA, Peters PJ, Brenner MB, Porcelli SA (1996) Cytoplasmic tail-dependent localization of CD1b antigen presenting molecules to MIICs. Science 273:349–352
Tanaka Y, Sano S, Nieves E, DeLibero G, Rosa D, Modlin R, Brenner MB, Bloom BR, Morita CT (1994) Nonpeptide ligands for human gammadelta T cells. Proc Natl Acad Sci USA 91:8175–8179
Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR (1995) Natural and synthetic non- peptide antigens recognized by human gamma delta T cells. Nature 375:155–158
Tascon RE, Colston MJ, Tagno S, Stavropoulos E, Gregory D, Lowrie DB (1996) Vaccination against tuberculosis by DNA injection. Nature Med 2:888–892
Thole JER, Wieles B, Clark-Curtiss JE, Ottenhoff THM, Rinke de Wit TF (1995) Immunological and functional characterization of Mycobacterium leprae protein antigens:an overview. Mol Microbiol 18:791–800
Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ (1995) Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J immunol 154:465–473
Turk BE, Jiang H, Liu JO (1996) Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production. Proc Natl Acad Sci USA 93:7552–7556
Turner J, Dockrell H (1996) Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 8:339–342
van Eden W (1991) Heat shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis. Immunol Rev 121:5–28
VanHeyningen TK, Collins H, Russell DG (1997) IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol 158:330–337
Weltman AC, Rose DN (1993) The safety of Bacille Calmette-Guerin vaccination in HIV infection and AIDS. Aids 7:149–157
Whalen C, Horsburgh CR, Hom D, Lahart C. Simberkoff M, Ellner J (1995) Accelerated course of human immunodefiency virus infection after tuberculosis. Am J Respir Crit Care Med 151:129–135
Yammura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL (1991) Defining protective responses to pathogens:cytokine profiles in leprosy lesions. Science 254:277–279
Young D, Lathigra R, Hendrix R, Sweetser D, Young RA (1988) Stress proteins are immune targets in leprosy and tuberculosis. Proc Natl Acad Sci USA 85:4267–4270
Young DB, Garbe TR (1991) Lipoprotein antigens of Mycobacterium tuberculosis. Res microbial 142:55–65
Young DB, Kaufmann SH, Hermans PW, Thole JE (1992) Mycobacterial protein antigens:a compilation. Mol Microbiol 6:133–145
Zaheer SA, Mukherjee R, Ramkumar B, Misra RS, Sharma AK, Kar HK, Kaur H, Nair S, Mukherjee A, Talwar GP (1993) Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J Infect Dis 167:401–410
Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF (1995) T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63:3231–3234
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Janssen, R., Young, D., Thole, J. (1999). Mycobacteria. In: Perlmann, P., Wigzell, H. (eds) Vaccines. Handbook of Experimental Pharmacology, vol 133. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59955-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-59955-2_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64196-1
Online ISBN: 978-3-642-59955-2
eBook Packages: Springer Book Archive